0
0
7/25/23 at 3:30am
Organization
Financial Express
41 words
0
Comments
After receiving EU approval late last year and US approval on July 17, 2023, Astrazeneca’s Beyfortus is set to reach global sales of $1.27 billion.
You are the first to view
https://www.financialexpress.com/healthcare/news-healthcare/preventative-measures-set-to-battle-for-rsv-market-domination-says-globaldata/3184987/
Create an account
or login to join the discussion